04:03 AM EST, 11/12/2024 (MT Newswires) -- Belite Bio ( BLTE ) reported a Q3 net loss Tuesday of $0.28 per diluted share, narrowing from a loss of $0.40 a year earlier.

Analysts surveyed by Capital IQ expected a loss of $0.29.

The company did not report any revenue for the quarter ended Sept. 30, as expected.

As of Sept. 30, the company had $109 million in cash, money market fund, time deposits and US treasury bills, it said.